指南与共识泌尿生殖腹部外周血管CTMR

ACR适宜性标准® 肾细胞癌分期:2022年更新

ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update.
指南 / 共识 · J Am Coll Radiol · 2023-01-01

美国放射学会适宜性标准2022年更新,针对肾细胞癌治疗前分期,基于GRADE与RAND/UCLA方法系统评价文献,由多学科专家组制定。CT和MRI是分期关键模态,需评估肿瘤侵犯肾窦、肾周脂肪、肾盂肾盏系统、肾上腺、肾静脉和下腔静脉,以及淋巴结和远处转移。

要点

  • CT和MRI是肾细胞癌分期关键模态,需评估肾窦和肾周脂肪侵犯。
  • 需报告肾盂肾盏系统受累、肾上腺浸润、肾静脉及下腔静脉受累。
  • 需评估转移性淋巴结肿大和远处转移的存在。

核心结论

  • 肾细胞癌为高度异质性肿瘤群,治疗前影像需准确评估原发肿瘤、淋巴结及远处转移。
  • 影响治疗的重要影像特征包括肿瘤侵犯肾窦和肾周脂肪、累及肾盂肾盏系统、浸润肾上腺、累及肾静脉和下腔静脉,以及转移性淋巴结肿大和远处转移。

研究设计与样本

  • 美国放射学会适宜性标准为针对特定临床情况的循证指南,由多学科专家组每年审阅。
  • 指南制定与修订过程支持对同行评审期刊医学文献的系统分析,采用GRADE等既定方法学原则评价证据。
  • RAND/UCLA适宜性方法用户手册提供确定特定临床场景影像和治疗程序适宜性的方法学。
  • 在同行评审文献缺乏或模棱两可时,专家可能是制定推荐意见的主要证据来源。

关键影像表现/征象

  • 肿瘤延伸至肾窦和肾周脂肪。
  • 累及肾盂肾盏系统。
  • 浸润肾上腺。
  • 累及肾静脉和下腔静脉。
  • 转移性淋巴结肿大和远处转移。

局限性

  • 在同行评审文献缺乏或模棱两可时,专家可能是制定推荐意见的主要证据来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Renal cell carcinoma is a complex group of highly heterogenous renal tumors demonstrating variable biological behavior. Pretreatment imaging of renal cell carcinoma involves accurate assessment of the primary tumor, presence of nodal, and distant metastases. CT and MRI are the key imaging modalities used in the staging of renal cell carcinoma. Important imaging features that impact treatment include tumor extension into renal sinus and perinephric fat, involvement of pelvicalyceal system, infiltration into adrenal gland, involvement of renal vein and inferior vena cava, as well as the presence of metastatic adenopathy and distant metastases. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Ganeshan D, Khatri G, Ali N, et al. ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update. J Am Coll Radiol. 2023. PMID: 37236747. doi:10.1016/j.jacr.2023.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。